StockData
Achieve Life Sciences, Inc. logo

Achieve Life Sciences, Inc. (ACHV) stock

ACHVNasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31Also trades as QUIT
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 4/30
$6.72+0.34 (+5.33%)

Close on Nov 6, 2026Market cap $691.50MP/E –Yield –

Achieve Life Sciences operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

Achieve Life Sciences's operating cash flow for the twelve months ending Jun 30, 2026 was -$47.02M. For fiscal 2025 it was -$49.47M. The highest annual figure on record is $34.88M in fiscal 2009.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$49.47M–
FY2024Dec 31, 2024-$29.77M–
FY2023Dec 31, 2023-$24.48M–
FY2022Dec 31, 2022-$37.57M–
FY2021Dec 31, 2021-$29.44M–
FY2020Dec 31, 2020-$13.47M–
FY2019Dec 31, 2019-$15.22M–
FY2018Dec 31, 2018-$10.62M–
FY2017Dec 31, 2017-$9.11M–
FY2016Dec 31, 2016-$202.00K–
FY2015Dec 31, 2015-$350.00K–
FY2014Dec 31, 2014-$17.31M–
FY2013Dec 31, 2013-$35.93M–
FY2012Dec 31, 2012-$43.49M–
FY2011Dec 31, 2011-$20.26M–
FY2010Dec 31, 2010-$26.84M-177.0%
FY2009Dec 31, 2009$34.88M–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$10.78M–
Q1 FY2026Mar 31, 2026-$6.93M–
Q4 FY2025Dec 31, 2025-$17.98M–
Q3 FY2025Sep 30, 2025-$11.33M–
Q2 FY2025Jun 30, 2025-$9.07M–
Q1 FY2025Mar 31, 2025-$11.09M–
Q4 FY2024Dec 31, 2024-$9.19M–
Q3 FY2024Sep 30, 2024-$10.37M–
Q2 FY2024Jun 30, 2024-$4.92M–
Q1 FY2024Mar 31, 2024-$5.29M–
Q4 FY2023Dec 31, 2023-$4.36M–
Q3 FY2023Sep 30, 2023-$5.14M–
Q2 FY2023Jun 30, 2023-$6.68M–
Q1 FY2023Mar 31, 2023-$8.30M–
Q4 FY2022Dec 31, 2022-$11.14M–
Q3 FY2022Sep 30, 2022-$11.31M–
Q2 FY2022Jun 30, 2022-$8.34M–
Q1 FY2022Mar 31, 2022-$6.78M–
Q4 FY2021Dec 31, 2021-$5.22M–
Q3 FY2021Sep 30, 2021-$8.69M–
Q2 FY2021Jun 30, 2021-$9.08M–
Q1 FY2021Mar 31, 2021-$6.45M–
Q4 FY2020Dec 31, 2020-$2.48M–
Q3 FY2020Sep 30, 2020-$4.34M–
Q2 FY2020Jun 30, 2020-$2.20M–
Q1 FY2020Mar 31, 2020-$4.46M–
Q4 FY2019Dec 31, 2019-$3.41M–
Q3 FY2019Sep 30, 2019-$3.07M–
Q2 FY2019Jun 30, 2019-$3.84M–
Q1 FY2019Mar 31, 2019-$4.89M–
Q4 FY2018Dec 31, 2018-$3.54M–
Q3 FY2018Sep 30, 2018-$2.98M–
Q2 FY2018Jun 30, 2018-$1.87M–
Q1 FY2018Mar 31, 2018-$2.23M–
Q4 FY2017Dec 31, 2017-$3.62M–
Q3 FY2017Sep 30, 2017-$5.46M-135.7%
Q2 FY2017Jun 30, 2017-$18.00K–
Q1 FY2017Mar 31, 2017-$11.00K–
Q4 FY2016Dec 31, 2016-$62.00K–
Q3 FY2016Sep 30, 2016$15.30M–

More Achieve Life Sciences figures

See a number that looks wrong?